MLSS
Price
$0.31Alerts
Change
+$0.02 (+6.90%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
27.36M
Earnings call today
Intraday BUY SELL Signals
NSPR
Price
$0.80Alerts
Change
+$0.03 (+3.90%)
Updated
Nov 11 closing price
Capitalization
32.6M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

MLSS vs NSPR

MLSS vs NSPR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLSS vs. NSPR commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLSS is a Hold and NSPR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MLSS with price predictions
Nov 11, 2026

MLSS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MLSS turned positive on October 29, 2026. Looking at past instances where MLSS's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MLSS's RSI Oscillator exited the oversold zone, 22 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLSS advanced for three days, in 179 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MLSS as a result. In 92 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLSS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for MLSS entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. MLSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.884) is normal, around the industry mean (4.964). P/E Ratio (-6.040) is within average values for comparable stocks, (40.591). MLSS's Projected Growth (PEG Ratio) (37.320) is very high in comparison to the industry average of (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.601) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for NSPR with price predictions
Nov 11, 2026

NSPR in upward trend: 10-day moving average moved above 50-day moving average on November 11, 2026

The 10-day moving average for NSPR crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on NSPR as a result. In 83 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for NSPR just turned positive on October 23, 2026. Looking at past instances where NSPR's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.

NSPR moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where NSPR advanced for three days, in 152 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

NSPR broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NSPR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.035) is normal, around the industry mean (4.142). P/E Ratio (-1.141) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.767) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. NSPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
MLSS vs NSPR: Fundamental Ratings
MLSS
NSPR
OUTLOOK RATING
1..100
1145
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
7846
P/E GROWTH RATING
1..100
1544
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NSPR's Valuation (42) in the Medical Specialties industry is somewhat better than the same rating for MLSS (98). This means that NSPR’s stock grew somewhat faster than MLSS’s over the last 12 months.

NSPR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MLSS (100). This means that NSPR’s stock grew similarly to MLSS’s over the last 12 months.

MLSS's SMR Rating (99) in the Medical Specialties industry is in the same range as NSPR (100). This means that MLSS’s stock grew similarly to NSPR’s over the last 12 months.

NSPR's Price Growth Rating (46) in the Medical Specialties industry is in the same range as MLSS (78). This means that NSPR’s stock grew similarly to MLSS’s over the last 12 months.

MLSS's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as NSPR (44). This means that MLSS’s stock grew similarly to NSPR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLSSNSPR
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 23 days ago
78%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (MLSS: $0.29 vs. NSPR: $0.77)
Brand notoriety: MLSS and NSPR are both not notable
MLSS represents the Pharmaceuticals: Other, while NSPR is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: MLSS: 108% vs. NSPR: 156%
Market capitalization -- MLSS: $27.36M vs. NSPR: $32.6M
MLSS [@Pharmaceuticals: Other] is valued at $27.36M. NSPR’s [@Medical/Nursing Services] market capitalization is $32.6M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLSS’s FA Score shows that 1 FA rating(s) are green while NSPR’s FA Score has 0 green FA rating(s).

  • MLSS’s FA Score: 1 green, 4 red.
  • NSPR’s FA Score: 0 green, 5 red.
According to our system of comparison, NSPR is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLSS’s TA Score shows that 4 TA indicator(s) are bullish while NSPR’s TA Score has 4 bullish TA indicator(s).

  • MLSS’s TA Score: 4 bullish, 3 bearish.
  • NSPR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MLSS is a better buy in the short-term than NSPR.

Price Growth

MLSS (@Pharmaceuticals: Other) experienced а -3.95% price change this week, while NSPR (@Medical/Nursing Services) price change was +17.60% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

MLSS is expected to report earnings on Nov 12, 2026.

NSPR is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+1.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and ANGO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and ANGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+6.10%
ANGO - MLSS
29%
Poorly correlated
+2.90%
ESTA - MLSS
26%
Poorly correlated
+5.15%
QDEL - MLSS
25%
Poorly correlated
+3.39%
GKOS - MLSS
25%
Poorly correlated
+4.64%
IDXX - MLSS
25%
Poorly correlated
+0.85%
More

NSPR and

Correlation & Price change

A.I.dvisor tells us that NSPR and LIVN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSPR and LIVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSPR
1D Price
Change %
NSPR100%
+3.40%
LIVN - NSPR
24%
Poorly correlated
-0.18%
MLSS - NSPR
23%
Poorly correlated
+6.10%
AVR - NSPR
23%
Poorly correlated
+5.26%
SNWV - NSPR
23%
Poorly correlated
-5.32%
CVRX - NSPR
23%
Poorly correlated
+0.70%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RELL20.120.85
+4.44%
Richardson Electronics Ltd
MNST45.400.06
+0.13%
Monster Beverage Corporation
ASB30.950.04
+0.13%
Associated Banc-Corp
MNY0.57N/A
+0.09%
MoneyHero Limited
DLX26.54-0.05
-0.19%
Deluxe Corp